- Home
- RNXT vs CLPS Comparison
RNXT vs CLPS Comparison
Compare RNXT & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CLPS
- Stock Information
- Founded
- RNXT 2012
- CLPS 2005
- Country
- RNXT United States
- CLPS Hong Kong
- Employees
- RNXT N/A
- CLPS N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CLPS Computer Software: Prepackaged Software
- Sector
- RNXT Health Care
- CLPS Technology
- Exchange
- RNXT Nasdaq
- CLPS Nasdaq
- Market Cap
- RNXT 31.6M
- CLPS 35.1M
- IPO Year
- RNXT 2021
- CLPS 2018
- Fundamental
- Price
- RNXT $1.03
- CLPS $1.27
- Analyst Decision
- RNXT Strong Buy
- CLPS
- Analyst Count
- RNXT 1
- CLPS 0
- Target Price
- RNXT $9.00
- CLPS N/A
- AVG Volume (30 Days)
- RNXT 214.8K
- CLPS 23.9K
- Earning Date
- RNXT 03-31-2025
- CLPS 03-04-2025
- Dividend Yield
- RNXT N/A
- CLPS 10.01%
- EPS Growth
- RNXT N/A
- CLPS N/A
- EPS
- RNXT N/A
- CLPS N/A
- Revenue
- RNXT N/A
- CLPS $142,812,726.00
- Revenue This Year
- RNXT N/A
- CLPS N/A
- Revenue Next Year
- RNXT N/A
- CLPS N/A
- P/E Ratio
- RNXT N/A
- CLPS N/A
- Revenue Growth
- RNXT N/A
- CLPS N/A
- 52 Week Low
- RNXT $0.77
- CLPS $0.68
- 52 Week High
- RNXT $1.86
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- RNXT 35.37
- CLPS 50.44
- Support Level
- RNXT $1.00
- CLPS $1.19
- Resistance Level
- RNXT $1.18
- CLPS $1.36
- Average True Range (ATR)
- RNXT 0.10
- CLPS 0.09
- MACD
- RNXT -0.03
- CLPS -0.00
- Stochastic Oscillator
- RNXT 6.00
- CLPS 47.37
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.